Occident Group

Lunaphore Technologies S.A. is a Swiss company developing next generation tissue autostainers for cancer research and tissue diagnostics. The award-winning technology based on microfluidics is called FFeX (Fast Fluidic Exchange). It aims to perform assays much faster than standard techniques and has demonstrated good results in tests with cancer patient samples. Lunaphore was founded in 2014 with the vision of bringing –omics like approaches to tissue analytics and has been recognized as one of the most innovative companies nationally and internationally.

Core Sensing makes components intelligent. Every metallic component becomes an intelligent force and torque sensor thanks to its wireless and integrated sensors. With its modular sensors and wireless measuring amplifiers, it can quickly put together a solution that is perfectly tailored to their application.

Invasight is a clinical biotech company that focused on revolutionizing cell invasion research. The company was founded in 2019 and is headquartered in Zurich, Switzerland.

Code Intelligence GmbH, founded in 2017 and based in Bonn, Germany, specializes in developing security software aimed at enhancing the reliability and security of software applications. The company offers modern security testing solutions utilizing coverage-based fuzzing techniques, which enable automated vulnerability detection and error checking with minimal expert intervention. Its products are designed for use by software developers, quality managers, and IT security firms, facilitating a continuous testing infrastructure that integrates the latest advancements in software testing technology. Code Intelligence serves prominent global clients, including Bosch, Deutsche Börse Group, and Deutsche Telekom, helping them ensure the security and robustness of their software systems.

Tubulis generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Their goal is to expand the therapeutic potential of antibody drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients.

hemotune AG develops medical device for the purification of blood in acute care. The company uses magnetic blood purification on the device to treat infections. hemotune AG was founded in 2016 and is based in Zürich, Switzerland.

Lunaphore Technologies S.A. is a Swiss company developing next generation tissue autostainers for cancer research and tissue diagnostics. The award-winning technology based on microfluidics is called FFeX (Fast Fluidic Exchange). It aims to perform assays much faster than standard techniques and has demonstrated good results in tests with cancer patient samples. Lunaphore was founded in 2014 with the vision of bringing –omics like approaches to tissue analytics and has been recognized as one of the most innovative companies nationally and internationally.

hemotune AG develops medical device for the purification of blood in acute care. The company uses magnetic blood purification on the device to treat infections. hemotune AG was founded in 2016 and is based in Zürich, Switzerland.

Tubulis generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Their goal is to expand the therapeutic potential of antibody drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients.

Code Intelligence GmbH, founded in 2017 and based in Bonn, Germany, specializes in developing security software aimed at enhancing the reliability and security of software applications. The company offers modern security testing solutions utilizing coverage-based fuzzing techniques, which enable automated vulnerability detection and error checking with minimal expert intervention. Its products are designed for use by software developers, quality managers, and IT security firms, facilitating a continuous testing infrastructure that integrates the latest advancements in software testing technology. Code Intelligence serves prominent global clients, including Bosch, Deutsche Börse Group, and Deutsche Telekom, helping them ensure the security and robustness of their software systems.

Lunaphore Technologies S.A. is a Swiss company developing next generation tissue autostainers for cancer research and tissue diagnostics. The award-winning technology based on microfluidics is called FFeX (Fast Fluidic Exchange). It aims to perform assays much faster than standard techniques and has demonstrated good results in tests with cancer patient samples. Lunaphore was founded in 2014 with the vision of bringing –omics like approaches to tissue analytics and has been recognized as one of the most innovative companies nationally and internationally.

Resistell is a antibiotic resistance test.

GNA Biosolutions is a molecular technology company located in Martinsried, Germany, specializing in innovative diagnostic devices for detecting and analyzing DNA. Their core technology, Pulse Controlled Amplification, enhances molecular testing by integrating ultrafast nucleic acid amplification with intrinsic sample preparation. This advancement allows for efficient and simplified diagnosis of human pathogens in laboratory settings, as well as on-site applications and Point of Care scenarios. GNA Biosolutions aims to make the benefits of molecular testing accessible to a broader audience, facilitating rapid and accurate results from sample collection to analysis.

Resistell is a antibiotic resistance test.

iThera Medical GmbH, founded in 2010 as a spin-off from the Helmholtz Zentrum München, specializes in biomedical imaging technology, particularly multi-spectral optoacoustic tomography (MSOT). Based in Munich, Germany, the company develops innovative photonic molecular imaging solutions that generate tissue images by utilizing intrinsic optical properties of tissues. iThera Medical's technology has diverse applications, including the analysis of angiogenesis, tumor hypoxia, and molecular probe distribution for cancer diagnosis and treatment. It also aids in imaging conditions related to cardiovascular diseases, such as cardiac arrhythmia and ischemia, along with neurodegenerative diseases and stroke. Additionally, the technology facilitates the visualization and quantification of changes in drug delivery and organ function, enhancing the understanding of biodistribution and pharmacokinetics of therapeutics and diagnostic probes. Through its commitment to advancing MSOT technology, iThera Medical aims to improve preclinical and clinical applications in various medical fields.

Lunaphore Technologies S.A. is a Swiss company developing next generation tissue autostainers for cancer research and tissue diagnostics. The award-winning technology based on microfluidics is called FFeX (Fast Fluidic Exchange). It aims to perform assays much faster than standard techniques and has demonstrated good results in tests with cancer patient samples. Lunaphore was founded in 2014 with the vision of bringing –omics like approaches to tissue analytics and has been recognized as one of the most innovative companies nationally and internationally.

Adivo GmbH is a veterinary biotechnology company based in Planegg, Germany, that specializes in the development of species-specific therapeutic antibodies for companion animals, particularly dogs. The company focuses on addressing serious diseases in pets and aims to extend its therapeutic offerings to other animal species. Adivo utilizes a fully synthetic, dog-specific drug library to select antibodies with optimal properties through phage display technology. As a spin-off of MorphoSys AG, Adivo benefits from extensive expertise in the development of human therapeutic antibodies, which the team applies to advance veterinary medicine.

InSphero AG develops organotypic biological 3D microtissues and microtissue-based assays for biochemical compounds screening and predictive drug testing applications. It offers human prostate and mammary carcinoma, and rat liver microtissues. The company also provides compound toxicity testing, cell-invasion assays, stem-cell research, cell-to-cell interaction, regenerative medicine, tissue engineering, and cell-to-extracellular matrix interaction services. In addition, it involves in study of transcriptomics, proteomics, and metabolomics. Further, the company provides custom development services, which include microtissue development, H and E stained paraffin sections, growth characteristics data, and morphometric data. Its microtissue system enables the generation of various model systems using either tumor-derived cells to reconstitute primary tumors or primary cells to mimic structure and function of diverse organ tissues. InSphero AG was founded in 2009 and is based in Zurich, Switzerland.

advanceCOR GmbH is a drug development company based in Munich, Germany, specializing in therapeutics and diagnostics for heart and vascular diseases. Founded in 2000, the company focuses on creating personalized treatments and has developed several innovative products. Notable among these is Revacept, a human Fc fusion protein that inhibits the local activation of platelets at vascular injury sites. Additionally, advanceCOR offers COR-2, a recombinant protein that reduces foam cell generation and cholesterol uptake, and COR-3, which targets atherosclerotic plaques while binding to progenitor cells to promote plaque healing. The company’s product pipeline also includes therapies for acute arterial thrombosis, myocardial infarction, stroke, and transient ischemic attack, emphasizing its commitment to addressing serious cardiovascular conditions.

Implandata Ophthalmic Products GmbH is a medical device company based in Hanover, Germany, specializing in innovative solutions for the treatment and management of glaucoma. Founded in 2010, the company has developed the Eyemate system, which features an implantable micro sensor designed for continuous intraocular pressure measurement. This technology aims to enhance the monitoring and therapy of glaucoma patients, providing eye care specialists with proactive and personalized guidance in treatment. By integrating advanced medical technology with information systems, Implandata addresses an underserved area in glaucoma care, facilitating more effective management for patients, their families, and healthcare providers.

Numbrs is a customer-centric financial services company. It enables its customers to manage their existing bank accounts and personal finances and to buy any financial product from every provider at the best possible price. Numbrs is not a bank and will not become a bank. The company is headquartered in Zurich, Switzerland and employs over 100 people.

Lunaphore Technologies S.A. is a Swiss company developing next generation tissue autostainers for cancer research and tissue diagnostics. The award-winning technology based on microfluidics is called FFeX (Fast Fluidic Exchange). It aims to perform assays much faster than standard techniques and has demonstrated good results in tests with cancer patient samples. Lunaphore was founded in 2014 with the vision of bringing –omics like approaches to tissue analytics and has been recognized as one of the most innovative companies nationally and internationally.

Versantis AG is a Swiss pharmaceutical company focused on developing innovative medicines and diagnostics for liver diseases. Founded in 2015 and based in Zurich, it originated as a spin-off from ETH Zurich. The company's lead candidate, VS-01, is in preclinical development and aims to address acute liver disease while supporting multiple failing organs, targeting three rare indications and having received Orphan Drug Designation for acute liver failure. Versantis also has products in its pipeline, including VS-02 and VS-03, which are designed to treat chronic liver diseases and drug intoxications, respectively. These treatments aim to meet significant unmet medical needs and have the potential to enhance patient outcomes across various medical fields.

Numbrs is a customer-centric financial services company. It enables its customers to manage their existing bank accounts and personal finances and to buy any financial product from every provider at the best possible price. Numbrs is not a bank and will not become a bank. The company is headquartered in Zurich, Switzerland and employs over 100 people.

Cunesoft GmbH is a provider of cloud-based regulatory compliance software solutions tailored for the life sciences industry. Established in 2013 and headquartered in Munich, Germany, with offices in Princeton, New Jersey, and Bengaluru, India, Cunesoft offers a range of Software as a Service (SaaS) products. These include cune-IDMP, a master data management tool for accessing external regulatory databases; cune-eCTD, which facilitates electronic submission creation; and cune-Track, a workflow management system for regulatory tasks. Additionally, the company provides cune-RDMS for document navigation and tagging, cune-SOP for standard operating procedures, and cune-Portal for sharing regulatory documents. Cunesoft also offers outsourcing services for regulatory procedures and documentation. The company’s software is designed for quick deployment and is utilized by both small and medium-sized enterprises and larger pharmaceutical divisions globally, emphasizing reliability, security, and compliance. Cunesoft operates as a subsidiary of Phlexglobal Ltd. since January 2020.

iMusician is a Swiss based music start up offering musicians everything they need to sell, manage and monetise their music online. Run by a small, international team who are passionate about music, They do the hard work so you can concentrate on what’s important to you: making music!

InSphero AG develops organotypic biological 3D microtissues and microtissue-based assays for biochemical compounds screening and predictive drug testing applications. It offers human prostate and mammary carcinoma, and rat liver microtissues. The company also provides compound toxicity testing, cell-invasion assays, stem-cell research, cell-to-cell interaction, regenerative medicine, tissue engineering, and cell-to-extracellular matrix interaction services. In addition, it involves in study of transcriptomics, proteomics, and metabolomics. Further, the company provides custom development services, which include microtissue development, H and E stained paraffin sections, growth characteristics data, and morphometric data. Its microtissue system enables the generation of various model systems using either tumor-derived cells to reconstitute primary tumors or primary cells to mimic structure and function of diverse organ tissues. InSphero AG was founded in 2009 and is based in Zurich, Switzerland.

iMusician is a Swiss based music start up offering musicians everything they need to sell, manage and monetise their music online. Run by a small, international team who are passionate about music, They do the hard work so you can concentrate on what’s important to you: making music!